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INTRODUCTION
Ever since ancient times, people relied on drugs from natural 
sources to cure their diseases [1], that is true since medicinal 
plants are considered to be the richest biological resource of 
drugs in traditional and modern medicine, food supplements, 
pharmaceuticals and intermediates for synthetic drugs, where it is 
estimated that 14-28% of higher plants are used medicinally [2]. 
The importance of plants as a source of medicine is depicted 
in a study by the World Health Organization, estimating that a 
substantial percentage of the population in developing countries 
relies on medicinal plants, where also people in developed 
countries are increasingly gaining interest in this domain [3].
Despite the fact that the pharmacological industries have 
produced a relatively limited number of new antibiotics in 
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ABSTRACT
Aim: In a search for finding novel therapeutic agents, extracts from an endemic Lebanese plant, Astragalus 
angulosus, were evaluated for their potential in-vitro antibacterial and antibiofilm activities against three 
Gram-positive bacterial strains; Staphylococcus epidermidis (CIP444), Staphylococcus aureus (ATCC25923), 
and Enterococcus faecalis (ATCC29212); in addition to two Gram-negative strains, Escherichia coli (ATCC35218) 
and Pseudomonas aeruginosa (ATCC27853). Materials and Methods: The plant was collected in April of 2013 
and divided into several different portions, then its extracts were obtained by maceration using two different 
solvents. Extract analysis followed directly where microtiter broth dilution method was employed to assess 
antibacterial activity, while antibiofilm potential was tested using colorimetric method. Results: Whole plant 
ethanolic extract showed the highest bacteriostatic effect at a concentration of 12.78 mg/ml and also was 
the most versatile exerting its effect against 3 different strains. Other extracts also exhibited an effect but at 
higher concentrations and each against a single strain. Regarding antibiofilm activity, the majority of the extracts 
were able to eradicate >50% of S. epidermidis preformed biofilm, where the highest activity was obtained 
with flower fraction extracted in water, achieving 67.7% biofilm eradication at 0.2 mg/ml. Conclusions: This 
plant possesses a promising potential in regard to eradicating bacteria and their biofilms and it is the first 
contributing step of establishing a library for the endemic Lebanese plants in this domain.
KEY WORDS: Antibacterial, antibiofilm, Astragalus angulosus, phytochemical screening, minimal inhibitory 
concentration, minimal bactericidal concentration
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the past few decades, microbial resistance to these drugs have 
increased [4]. This problem was further accentuated by the 
over prescription and misuse of traditional antibiotics [5]. 
Furthermore, modern synthetic medication poses a major risk 
to patients’ health where such adverse drug reactions (ADRs) 
occur almost daily in medium sized hospitals and outpatient 
panels; this results in substantial morbidity and mortality in 
addition to the decreasing efficacy of these products [1,6]. In 
addition to the previous implications, drug resistance severely 
increases the cost of medical care where the estimated cost of 
treating a case of tuberculosis (including drugs, procedures, and 
hospitalization) increases from $12,000 for a drug-susceptible 
strain to $180,000 for a multidrug-resistant strain [7]. Therefore, 
the decreasing efficacy of synthetic drugs and the increasing 
contraindications of their usage make the usage of natural drugs 
an encouraging need again [1].
Another concern of the work at hand focuses on bacterial 
biofilms which can be defined as a community of microorganisms 
attached to a surface and embedded in their self-produced 
matrix. Moreover, organisms in this state of existence will 
exhibit new phenotypic characteristics rather than that of the 
planktonic state [8]. More specifically in the current study, 
we will be dealing with Staphylococcus epidermidis biofilms, 
in which the strain used here (CIP444) was isolated from an 
infected implanted device [9]. We are interested specifically in 
the S. epidermidis biofilm since although it is usually described 
as a commensal species and a permanent colonizer of human 
skin, it is among the most common sources of infections on 
indwelling medical devices [10].
Biofilms can be very problematic in various aspects of our 
lives ranging from medical to industrial areas. In addition to 
their increased resistance to antimicrobial agents, biofilms can 
form on many medical implants such as catheters, artificial 
hips, and contact lenses. The most worrisome fact is that cells 
existing in a biofilm can become 10-1000 times more resistant 
to antimicrobial agents, mainly through the production of 
extracellular polymeric substance matrix that hinders the access 
of antibiotics to the bacterial cells. These infections can often 
only be treated by removal of the implant, thus increasing the 
trauma to the patient and the cost of the treatment. It has been 
estimated that biofilms are associated with 65% of nosocomial 
infections and that treatment of these biofilm-based infections 
costs >$1 billion annually [11].
Therefore, it is of utmost importance to seek a novel 
therapeutic agent that has a minimum impact on patient’s 
health and is cost-effective. The concern to unravel better and 
safer ways to treat microbial infections and their consequences 
encouraged us to hunt for natural products that might provide 
such solution. To achieve our goal, we have relied on plant 
secondary metabolites such as phenols, saponins, flavonoids 
and many others that possess antimicrobial potential [2]. Our 
chosen plant in this work is a species endemic to Lebanon, 
Astragalus angulosus, whose extracts were used in antibacterial 
and antibiofilm testing in an aim to unravel a new therapeutic 
agent.
MATERIALS AND METHODS
Plant Material
A. angulosus was collected from Yammouneh in Bekaa 
(34.116046, 36.037830) during its flowering period in April 
(2013). It was identified in accordance with the two well-known 
guides of Lebanon’s flora [12,13].
Preparation of the Extracts
The plant was rinsed and divided into several fractions; whole 
plant, flowers, leaves, green stems, and brown stems. The 
phytochemicals were extracted by maceration and performed 
over multiple stages where after finely chopping the plant 
portions, each fraction (50-100 g according to the abundance of 
each part) was fully submerged in a suitable volume of distilled 
water and ethanol (100%) in separate light blocking beakers 
and agitated at ambient temperature for 8-12 h then for the 
same duration at 37°C. They were then filtered and the process 
repeated for the obtained marks. Finally, the resulting fractions 
were concentrated using a rotary evaporator under reduced 
pressure at 60°C for aqueous and 40°C for ethanolic fractions, 
and finally, they were frozen at −80°C and freeze-dried using a 
lyophilizer (Christ Alpha 1-4 LDplus, Martin Christ, Germany) 
for 2-3 days at −20°C to obtain the powders to study. To assess 
the obtained powders, they were dissolved in sterile distilled 
water, and aliquots with a defined concentration were prepared 
for further analysis.
Phytochemical Screening
For the purpose of this test, aliquots from the ethanolic and 
water extract of each fraction of the plant were prepared and 
evaluated by phytochemical qualitative reactions for common 
plant secondary metabolites; these include tannins, resins, 
coumarins, saponins, alkaloids, phenols, terpenoids, volatile oils, 
and flavonoids [14-16]. The results were evaluated according to 
the response of the extract to these tests, mainly color change 
and/or precipitate formation.
Antibacterial Testing
Bacterial strains, media, and reagents
Five referenced strains belonging either to the American 
Type Culture Collection or to the Collection of “Institut 
Pasteur” were used in this study. Three Gram-positive strains, 
S. epidermidis (CIP444), Staphylococcus aureus (ATCC25923), 
and Enterococcus faecalis (ATCC29212); two Gram-negative 
strains, Escherichia coli (ATCC35218) and Pseudomonas 
aeruginosa (ATCC27853). CIP444 is a strain that was isolated 
from a patient with an infected implanted device in the Mignot 
hospital of Versailles, France [9].
This strain was identified and characterized for many features 
by Pr. Ali Chokr and deposited to be enclosed within the 
micro-organisms of the collection of “Institut Pasteur” 
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in 2007 [9,17-19]. All strains were stored at −80°C in glycerol 
stocks and used as required. Brain heart infusion broth/agar 
(BHI/BHA), tryptone soya broth (TSB) and Mueller-Hinton 
broth (MHB) were purchased from HIMEDIA (Mumbai, India) 
and then prepared as per indicated by the manufacturer.
Minimal inhibitory concentration (MIC) and minimal 
bactericidal concentration (MBC) assays
MICs and MBCs were determined using the microtiter broth 
dilution method as recommended by the Clinical and Laboratory 
Standards Institute [20]. The different bacterial strains were 
grown in BHI overnight and then bacterial suspensions of each 
were prepared using MHB at 5 × 105 CFU/ml (confirmed by 
viable count) to be used for inoculation. 100 µl of each extract 
was used to perform serial two-fold dilutions in MHB using a 
96-well flat-bottom polystyrene tissue culture-treated microtiter 
plate (Corning®Costar® 3598; Corning, NY 14831, USA) then 
100 µl of the previously prepared suspensions were inoculated 
into each well. Positive growth control lacking any plant extract 
and negative growth control lacking a bacterial inoculum were 
taken into account. The plates were then incubated at 37°C 
for 24 h, the MIC of each extract was the lowest concentration 
with no visible growth in its corresponding well. Then, all wells 
with no visible growth were plated on BHA to determine the 
MBC which is the lowest concentration able to reduce the initial 
bacterial inoculum by >99.9%. For comparison, these strains 
were tested using the same procedure against standard common 
antibiotics including tetracycline, nalidixic acid, polymyxin, 
rifampicin, and ampicillin (results not shown).
Antibiofilm Susceptibilty Testing against a Preformed 
Biofilm
Biofilm formation
Assay of biofilm formation in polystyrene plates was performed 
essentially according to a standard procedure [21], where 
S. epidermidis (CIP444) was grown in TSB medium overnight 
at 37°C, then a bacterial suspension of concentration 
4.16 × 105 CFU/ml was prepared in TSB supplemented 
with 0.25% glucose. 120 µl of this bacterial suspension were 
inoculated into each well of a sterile 96-well flat bottom plate 
except for column 12 that was used as a control and filled only 
with sterile TSB medium; then, the plates were incubated 
for 24 h at 37°C. The biomass and any non-adherent bacteria 
were then discarded by gently washing the plates with 0.9% 
NaCl physiologic water and the remaining biofilm was fixed 
by incubating the plates for 50 min at 50°C [9].
Antibiofilm activity assay
After the fixation of the formed biofilm as previously described, 
each well of the microtiter plate was filled with 100 µl of sterile 
physiologic water for use as a diluent of our plant extracts. The 
serial 1:2 dilution was then performed with 100 µl of each plant 
extract, and the plates were then incubated at 37°C during 18 
h. Tests were performed in quadruple. The wells were then 
washed 2 times with saline water, filled with 100 µl of crystal 
violet 0.1% and incubated at room temperature for 10 min. The 
stain is then discarded, and the wells are washed 3 times with 
saline water. Finally, they were filled with 100 µl of physiologic 
water and the OD490 nm is measured. One microtiter plate 
was skipped of treatment with the plant extracts and used as 
an untreated positive control.
Statistical Analysis
Antibiofilm tests were performed in quadruple, and the 
results were expressed as mean values ± standard errors of the 
means. Differences in the biofilm eradication potentials were 
evaluated by an unpaired non-parametric analysis of variance 
(Kruskal-Wallis test) followed by Dunn’s multiple comparisons 
test of each mean versus the mean of the untreated (positive) 
control. Approximate eradication efficiency (percentage) 
was calculated according to the following equation: (Average 
[control wells]−Average (treated wells)/Average (control 
wells)]×100. GraphPad Prism® Software (Version 6.05; 
GraphPad Software, Inc.) was used for statistical analysis, 
considering a P < 0.05 to be statistically significant.
RESULTS
Phytochemical Screening
Saponins, coumarins, and flavonoids were present in all 
fractions and portions of this plant as represented in Table 1. 
Other secondary metabolites were also present but in variable 
amounts with respect to the different fractions, and noticeably 
low abundance of volatile oils and complete absence of the 
tannins.
MIC and MBC Results
After testing the extracts according to the method specified 
earlier, the entire raw findings are displayed in Table 2. For 
some extracts, no MIC and/or MBC was obtained at the used 
concentration and hence the symbol (>) was used to indicate 
that a higher concentration might be needed to achieve an 
effect.
Among the 10 extracts, only 5 exhibited a bacteriostatic effect. 
The most significant being whole plant ethanolic fraction which 
exerted its effects on three bacterial strains (S. epidermidis, 
E. coli, and P. aeruginosa), with the lowest being 12.78 mg/ml 
for S. epidermidis as shown in Figure 1 and it is also notable that 
P. aeruginosa was the most sensitive organism where 3 fractions 
were able to suppress its growth (brown stem ethanolic, aqueous 
green stem and whole plant ethanolic fractions) with the 
lowest being that of whole plant ethanolic at 102.2 mg/ml. The 
other fractions’ MICs ranged between 188.7 mg/ml for leaves 
ethanolic on S. epidermidis to 546 mg/ml of flowers ethanolic 
fraction on S. aureus.
Regarding the MBC, only the whole plant ethanolic fraction was 
active among the 10 extracts as seen in Figure 2, and against 3 of 
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the tested strains, ranging from 102.2 mg/ml for S. epidermidis 
to 204.5 mg/ml for E. coli and P. aeruginosa.
Antibiofilm Activity Results
As demonstrated in Figures 3 and 4, in general, all our extracts were 
able to eradicate the S. epidermidis preformed biofilm but with 
variable patterns. For example, flower, brown stem and whole plant 
(water and ethanol fraction) also green stem and leaves (water 
fraction) extracts performed better under lower concentrations, 
and this was confirmed also by the statistical analyses performed. 
While green stem and leaves (ethanolic fraction) extracts had 
better eradication capacities at higher concentrations.
As shown in Figure 3, the highest overall significance belongs to the 
flower water extract which also achieved the highest eradication 
activity at a very low concentration (~67.7% at 0.2 mg/ml, 
P < 0.0001). Other extracts followed the same pattern such as 
flower ethanol (~62.5% at 0.4 mg/ml, P < 0.01), brown stem, and 
whole plant (both fractions) in addition to green stem and leaves 
(water fraction) but with a lesser impact and significance. By 
contrast, we noticed that green stem (ethanolic fraction) exerted 
best eradication efficiency at higher concentrations (~56.5% at 
701.3 mg/ml, P < 0.001) and the same goes for leaves ethanolic 
fraction, but the overall test was insignificant according to the 
Kruskal-Wallis evaluation regarding the latter.
DISCUSSION
Increasing drug resistance to traditional treatments observed 
in several bacterial strains, in addition to harmful ADRs and 
substantial cost of treatment shifted the pace toward finding 
novel therapeutic agents, natural products such as plants and 
plant-derived compounds were the primary target due to their 
efficacy, safety, and lower cost.
Native to China, Astragalus has been used for centuries in 
traditional Chinese medicine. There are actually over 2,000 
species of Astragalus; however, the two related species - Astragalus 
membranaceus and Astragalus mongholicus - are the ones 
primarily used for health purposes [22].
Historically, Astragalus has been used in traditional medicine. 
Usually in combination with other herbs, as antioxidant, to 
support and enhance the immune system, for chronic hepatitis, 
other viral infections and as an adjunctive therapy for cancer. It 
is also used as a folk or traditional remedy for colds and upper 
respiratory infections, and for heart disease [23-26].
The biological activities of the Lebanese plants are not well 
explored. Only a few studies on some biological activities 
of certain plant genera such as Allium and Berberis are 
available [27-29].
To the best of our knowledge, the activities of the endemic 
Lebanese plants are not yet studied.
In this study, we chose a Lebanese endemic species of Astragalus 
which is A. angulosus in an effort to find novel agents that 
Table 1: Results of phytochemical screening of A. angulosus
Plant part Extraction solvent Alkaloids Tannins Resins Phenol Saponins Flavonoids Terpenoids Coumarins Volatile oil
Flower Ethanol + − − ++ + ++ − + −
Water + − + +++ +++ ++ ++ + −
Green stem Ethanol ++ − + ++ + ++ ++ + −
Water − − ++ + − − − ++ −
Brown stem Ethanol − − ++ − + + +++ + −
Water + − − + +++ + − + −
Leaves Ethanol − − ++ ‑ + + + ++ ++
Water +++ − + + ++ +++ − ++ −
Whole plant Ethanol + − − + + + − + +
Water + − ++ − +++ + − + −
−: Absence, +: Small amount, ++: Average amount, +++: Large amount
Figure 1: Significant minimal inhibitory concentration results of the 
tested fractions of Astragalus angulosus (E: Ethanol, W: Water)
Figure 2: Minimal bactericidal concentration results of the active 
bactericidal extract of Astragalus angulosus
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could aid in fighting bacterial infections and their biofilms. In 
the present work, we assessed and tested for the first time the 
antibacterial and antibiofilm activities of water and ethanolic 
extracts from the flower, leaves, brown stem, green stem, and 
whole plant portions of A. angulosus against five bacterial strains.
MIC and MBC values indicate that not all extracts exhibited 
an activity. Regarding the MIC assay, only 5 out of 10 were 
able to inhibit bacterial growth, among which the whole plant 
ethanolic fraction was most significant where it achieved the 
lowest MIC and had an effect against multiple strains. We also 
noticed that one of our tested strains, E. faecalis was insensitive 
to all treatments used, that is, independently of the strain 
being a Gram-positive one but rather probably related to the 
strain itself or the nature of our extracts and their targets. It is 
worthy to note that the most successful extracts contained fair 
amounts of several secondary metabolites mainly flavonoids, 
coumarins, and volatile oils. Furthermore, it was evident that 
most of the active extracts were ethanolic fraction extracts, 
which are characterized by containing flavonoids and phenols 
that are known antimicrobial agents [30,31].
It is not surprising that bactericidal activity was also detected 
with our leading extract which is the whole plant ethanolic 
fraction, which was the only extract with bactericidal activity 
and that was against 3 strains as well. This could be due to a 
potential synergistic effect between the different phytochemical 
constituents found in the whole plant. The synergism effect in 
plant extracts was also highlighted in literature as in the study 
of Ncube et al., in 2012, on the antimicrobial synergism within 
plant extract combinations from three South African medicinal 
bulbs [32].
The other problem at hand is the infections caused by biofilm-
related formation on indwelling medical devices, where the 
introduction of synthetic and artificial devices into body systems 
have provided the microorganisms with a way for evading host 
defenses and invading the host [33,34], where S. epidermidis 
is a major cause of these infections. This issue is not to be 
taken lightly where research has shown that an important 
cause of nosocomial infections is the catheter-associated 
bloodstream infections, with an estimated occurrence of 
50,000-100,000 cases a year in the United States with the skin 
being the most common source of organisms causing catheter-
related infections [35].
Our tests evaluated the ability of the extracts to disrupt and 
eradicate preformed biofilms, and the results were quite 
promising. We noticed a significant effect of some extracts, 
especially the flower water fraction in biofilm eradication and 
at low concentrations. Therefore, exposure to subinhibitory 
concentrations of some of our extracts could substantially 
affect the preformed S. epidermidis biofilms. We also observed 
that while some extracts showed better performance at higher 
concentrations, others were to some extent active irrespective 
of the used concentration.
By contrast to the antibacterial activity tests, the most 
successful extracts in the antibiofilm activity assays where Ta
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the water extracts that contained higher saponin content, 
which prompt us to hypothesize that it may have been acting 
as a kind of detergent against the preformed biofilms without 
excluding the effects of the other metabolites detected here 
such as alkaloids, resins, and phenols which are slightly more 
frequent in water extracts than in ethanolic ones. This is 
corroborated by the fact that our test involved preformed 
biofilm and as such the mode of action of the extracts in this 
test would be different, and that is, due to the absence of 
any bacteria in our biofilms where we were trying to combat 
the structure of the biofilm left by the bacteria and not the 
bacteria themselves.
This is supported by a study of Ye et al., in 2015, on the plant 
Camellia oleifera. They found that the extracts of this plant 
were rich in saponin identified as camelliagenin which shows 
significant inhibition on the biofilm of E. coli and S. aureus 
and it is related to the decrease of a component of the bacterial 
biofilm, the extracellular DNA. On the other hand, in 2015, 
Santiago et al. showed that Acalypha wilkesiana fraction extracts 
rich in saponins prevent the biofilm formation by methicillin-
resistant S. aureus (MRSA). Bioactive fraction rich in saponins 
inhibited the production of MRSA biofilm by preventing the 
initial cell-surface attachment [36,37].
After observing the “disjunction” between the active extracts 
in antibacterial tests and antibiofilm tests, it was clear that 
some extracts could decrease the viability of preformed biofilms 
through mechanism(s) that are different from mere growth 
inhibition of bacterial cells in the planktonic form. Therefore, 
in our view, there are different compounds responsible for the 
results seen in our performed tests and further analysis should 
be done to try to pinpoint the exact effectors.
In end, we can say that the results obtained in this study, taken 
together, provide promising evidence on the antibacterial 
and antibiofilm potential and effectiveness of the Lebanese 
endemic plant A. angulosus. Further biochemical testing and 
the separation of the secondary metabolites by chromatography 
methods are required to identify the exact compounds 
responsible for the observed effects. The ability of the extracts 
to prevent biofilm formation rather than just its eradication, 
Figure 3: Biofilm eradication potential of 4 Astragalus angulosus extracts against a preformed Staphylococcus epidermidis biofilm assessed by 
spectrophotometric method. Results are displayed as mean biofilms plus standard error of the mean. •P<0.05, ••P<0.01, •••P<0.001, ••••P<0.0001 
(analysis of variance by Kruskal-Wallis test). *P<0.05, **P<0.01, ***P<0.001 (Dunn’s post-test comparing the mean biofilm for each category 
(extract concentration) with that of the untreated control, OD490: Optical density at 490 nm
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then antioxidant, anticoagulant, and other biological activities, 
in addition to their toxicity on human cells remain to be further 
elucidated.
Our results showed that at relatively low concentrations 
some of our extracts displayed promising antibacterial 
and antibiofilm capabilities making them attractive for 
additional studies where we can hopefully label them as “novel 
therapeutic agents.”
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